tiprankstipranks
Trending News
More News >
CareDx (CDNA)
NASDAQ:CDNA
US Market

CareDx (CDNA) Stock Forecast & Price Target

Compare
835 Followers
See the Price Targets and Ratings of:

CDNA Analyst Ratings

Moderate Buy
6Ratings
Moderate Buy
2 Buy
4 Hold
0 Sell
Based on 6 analysts giving stock ratings to
CareDx
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

CDNA Stock 12 Month Forecast

Average Price Target

$25.00
▲(40.92% Upside)
Based on 6 Wall Street analysts offering 12 month price targets for CareDx in the last 3 months. The average price target is $25.00 with a high forecast of $28.00 and a low forecast of $21.00. The average price target represents a 40.92% change from the last price of $17.74.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"11":"$11","20":"$20","29":"$29","15.5":"$15.5","24.5":"$24.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":28,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$28.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":25,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$25.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":21,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$21.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[11,15.5,20,24.5,29],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jun<br/>2025","6":"Sep<br/>2025","9":"Dec<br/>2025","12":"Mar<br/>2026","25":"Mar<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,18.745,19.45692307692308,20.168846153846154,20.880769230769232,21.59269230769231,22.304615384615385,23.016538461538463,23.728461538461538,24.440384615384616,25.152307692307694,25.86423076923077,26.576153846153847,27.288076923076922,{"y":28,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,18.745,19.226153846153846,19.707307692307694,20.18846153846154,20.669615384615387,21.15076923076923,21.631923076923076,22.113076923076925,22.59423076923077,23.075384615384614,23.556538461538462,24.037692307692307,24.518846153846155,{"y":25,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,18.745,18.91846153846154,19.091923076923077,19.265384615384615,19.438846153846153,19.61230769230769,19.785769230769233,19.95923076923077,20.13269230769231,20.306153846153848,20.479615384615386,20.653076923076924,20.826538461538462,{"y":21,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":22.15,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.7,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.07,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.08,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.85,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.22,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.85,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 30, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 51, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 52, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.18,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 38, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.84,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.42,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.745,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$28.00Average Price Target$25.00Lowest Price Target$21.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on CDNA
H.C. Wainwright
H.C. Wainwright
$26$25
Hold
40.92%
Upside
Reiterated
03/09/26
CareDx: Solid Near-Term Execution vs. Reimbursement Headwinds and Long-Dated Pipeline Upside Justify Hold Rating
Craig-Hallum Analyst forecast on CDNA
Craig-Hallum
Craig-Hallum
Hold
Assigned
02/25/26
Analysts Offer Insights on Healthcare Companies: CareDx (NASDAQ: CDNA) and Atai Beckley N.V. (NASDAQ: ATAI)
Wells Fargo
$18$21
Hold
18.38%
Upside
Reiterated
02/25/26
Analysts Offer Insights on Healthcare Companies: Harmony Biosciences Holdings (NASDAQ: HRMY), CareDx (NASDAQ: CDNA) and Sotera Health (NASDAQ: SHC)
William Blair Analyst forecast on CDNA
William Blair
William Blair
Hold
Reiterated
02/25/26
CareDx: Conservative Revenue Upside Offset by Weaker Margins and Coverage Uncertainty Justifying Hold Rating
BTIG
$26
Buy
46.56%
Upside
Reiterated
02/25/26
CareDx: Strong Growth, Discounted Valuation, and Emerging Oncology Optionality Support Buy Rating
Stephens Analyst forecast on CDNA
Unknown Analyst
Stephens
Not Ranked
Stephens
$28
Buy
57.84%
Upside
Reiterated
02/25/26
Stephens Reaffirms Their Buy Rating on CareDx (CDNA)
Raymond James Analyst forecast on CDNA
Unknown Analyst
Raymond James
Not Ranked
Raymond James
Hold
Reiterated
08/22/25
Raymond James Remains a Hold on CareDx (CDNA)
Nephron
$28
Buy
57.84%
Upside
Upgraded
07/09/25
CareDx upgraded to Buy from Hold at Nephron ResearchCareDx upgraded to Buy from Hold at Nephron Research
Goldman Sachs Analyst forecast on CDNA
Goldman Sachs
Goldman Sachs
$34$26
Buy
46.56%
Upside
Reiterated
04/16/25
CareDx, Inc (CDNA) PT Lowered to $26 at Goldman SachsGoldman Sachs analyst Matthew Sykes lowered the price target on CareDx, Inc (NASDAQ: CDNA) to $26.00 (from $34.00) while maintaining a Buy rating.
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on CDNA
H.C. Wainwright
H.C. Wainwright
$26$25
Hold
40.92%
Upside
Reiterated
03/09/26
CareDx: Solid Near-Term Execution vs. Reimbursement Headwinds and Long-Dated Pipeline Upside Justify Hold Rating
Craig-Hallum Analyst forecast on CDNA
Craig-Hallum
Craig-Hallum
Hold
Assigned
02/25/26
Analysts Offer Insights on Healthcare Companies: CareDx (NASDAQ: CDNA) and Atai Beckley N.V. (NASDAQ: ATAI)
Wells Fargo
$18$21
Hold
18.38%
Upside
Reiterated
02/25/26
Analysts Offer Insights on Healthcare Companies: Harmony Biosciences Holdings (NASDAQ: HRMY), CareDx (NASDAQ: CDNA) and Sotera Health (NASDAQ: SHC)
William Blair Analyst forecast on CDNA
William Blair
William Blair
Hold
Reiterated
02/25/26
CareDx: Conservative Revenue Upside Offset by Weaker Margins and Coverage Uncertainty Justifying Hold Rating
BTIG
$26
Buy
46.56%
Upside
Reiterated
02/25/26
CareDx: Strong Growth, Discounted Valuation, and Emerging Oncology Optionality Support Buy Rating
Stephens Analyst forecast on CDNA
Unknown Analyst
Stephens
Not Ranked
Stephens
$28
Buy
57.84%
Upside
Reiterated
02/25/26
Stephens Reaffirms Their Buy Rating on CareDx (CDNA)
Raymond James Analyst forecast on CDNA
Unknown Analyst
Raymond James
Not Ranked
Raymond James
Hold
Reiterated
08/22/25
Raymond James Remains a Hold on CareDx (CDNA)
Nephron
$28
Buy
57.84%
Upside
Upgraded
07/09/25
CareDx upgraded to Buy from Hold at Nephron ResearchCareDx upgraded to Buy from Hold at Nephron Research
Goldman Sachs Analyst forecast on CDNA
Goldman Sachs
Goldman Sachs
$34$26
Buy
46.56%
Upside
Reiterated
04/16/25
CareDx, Inc (CDNA) PT Lowered to $26 at Goldman SachsGoldman Sachs analyst Matthew Sykes lowered the price target on CareDx, Inc (NASDAQ: CDNA) to $26.00 (from $34.00) while maintaining a Buy rating.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering CareDx

3 Months
xxx
Success Rate
4/9 ratings generated profit
44%
Average Return
+3.51%
reiterated a xxx
rating 11 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 44.44% of your transactions generating a profit, with an average return of +3.51% per trade.
1 Year
Matthew SykesGoldman Sachs
Success Rate
2/9 ratings generated profit
22%
Average Return
-31.80%
reiterated a buy rating 11 months ago
Copying Matthew Sykes's trades and holding each position for 1 Year would result in 22.22% of your transactions generating a profit, with an average return of -31.80% per trade.
2 Years
xxx
Success Rate
4/9 ratings generated profit
44%
Average Return
+3.51%
reiterated a xxx
rating 11 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 44.44% of your transactions generating a profit, with an average return of +3.51% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CDNA Analyst Recommendation Trends

Rating
Nov 25
Dec 25
Jan 26
Feb 26
Mar 26
Strong Buy
1
0
0
1
1
Buy
17
22
21
12
6
Hold
52
38
16
15
15
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
70
60
37
28
22
In the current month, CDNA has received 7 Buy Ratings, 15 Hold Ratings, and 0 Sell Ratings. CDNA average Analyst price target in the past 3 months is 25.00.
Each month's total comprises the sum of three months' worth of ratings.

CDNA Financial Forecast

CDNA Earnings Forecast

Next quarter’s earnings estimate for CDNA is -$0.06 with a range of -$0.11 to -$0.04. The previous quarter’s EPS was -$0.08. CDNA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year CDNA has Performed in-line its overall industry.
Next quarter’s earnings estimate for CDNA is -$0.06 with a range of -$0.11 to -$0.04. The previous quarter’s EPS was -$0.08. CDNA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year CDNA has Performed in-line its overall industry.

CDNA Sales Forecast

Next quarter’s sales forecast for CDNA is $102.28M with a range of $100.60M to $104.10M. The previous quarter’s sales results were $108.39M. CDNA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year CDNA has Performed in-line its overall industry.
Next quarter’s sales forecast for CDNA is $102.28M with a range of $100.60M to $104.10M. The previous quarter’s sales results were $108.39M. CDNA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year CDNA has Performed in-line its overall industry.

CDNA Stock Forecast FAQ

What is CDNA’s average 12-month price target, according to analysts?
Based on analyst ratings, CareDx’s 12-month average price target is 25.00.
    What is CDNA’s upside potential, based on the analysts’ average price target?
    CareDx has 40.92% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is CDNA a Buy, Sell or Hold?
          CareDx has a consensus rating of Moderate Buy which is based on 2 buy ratings, 4 hold ratings and 0 sell ratings.
            What is CareDx’s price target?
            The average price target for CareDx is 25.00. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $28.00 ,the lowest forecast is $21.00. The average price target represents 40.92% Increase from the current price of $17.74.
              What do analysts say about CareDx?
              CareDx’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 6 Wall Streets Analysts.
                How can I buy shares of CDNA?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.